在变富之前变老:世卫组织东南亚地区对与衰老有关的政策干预措施的范围审查
Anu Mohan1, Teddy Andrews Jaihind Jothikaran2, Nachiket Gudi3
1Department of Social and Health Innovation, Prasanna School of Public Health, Manipal, Karnataka, India.
BMJ open
|January 6, 2025
概括
世界卫生组织东南亚地区 (WHO SEARO) 的政策干预措施涉及医疗保健和社会保障的老年护理. 在监测,标准,农村支持和去中心化方面存在差距,需要加强以更好地应对人口老龄化.
科学领域:
- 老年学与公共卫生政策
- 老龄化和老年护理干预措施
- 全球卫生政策分析 全球卫生政策分析
背景情况:
- 世界卫生组织东南亚地区 (WHO SEARO) 拥有194亿人口,占全球人口的很大一部分.
- 该地区面临着人口老龄化日益增长的挑战,需要对现有的政策干预措施进行审查.
研究的目的:
- 对世卫组织SEARO国家实施的政策干预措施进行范围审查,以应对衰老的后果.
- 确定和描述该地区的老年护理政策的范围.
主要方法:
- 使用阿克西和奥马利框架进行范围审查.
- 在五个数据库 (PubMed,Embase,Web of Science,Scopus,Google Scholar) 和灰色文献中进行了全面的搜索.
- 确定并分析了10篇文章和33个灰色文献来源,详细介绍了世卫组织SEARO国家老年护理干预措施.
主要成果:
- 主要干预领域包括医疗保健,长期护理,康复,福利和老年社会保障.
- 现有的政策涵盖了老龄化和老年护理的各个方面,各种法律,立法和计划都证明了这一点.
- 确定的局限性包括模两可的计划监测,缺乏评估基准,对农村贫困的关注不足,以及不充分的去中心化.
结论:
- 世卫组织认为,各国应该加强对护理人员的支持,为老年护理提供公共资金,以及老年健康保险.
- 加强在护理服务和社会保障系统 (包括养老金) 中的公私伙伴关系至关重要.
- 解决已发现的政策缺口对于更有效地对人口老龄化作出区域应对至关重要.
相关概念视频
The Effect of Aging on Tissues
3.6K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.6K
Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
861
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
861
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
382
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
382
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
400
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
400
Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367


